Assignee
AUTOLUS LTD
GB53 patents
Top patents by PatentIndex Score
US11091532B2Aug 17, 2021
T cell which co-expresses a CD19 chimeric antigen receptor and a CD22 chimeric antigen receptor
AUTOLUS LTD8 citations84
US11034750B2Jun 15, 2021
Chimeric antigen receptor (CAR) comprising a CD19-binding domain
AUTOLUS LTD8 citations84
US10981970B2Apr 20, 2021
Chimeric antigen receptor (CAR) comprising a CD22-binding domain
AUTOLUS LTD4 citations84
US11440961B2Sep 13, 2022
Anti TRBC1 antigen binding domains
AUTOLUS LTD7 citations83
US11434293B2Sep 6, 2022
Anti TRBC1 antigen binding domains
AUTOLUS LTD7 citations83
US10800854B2Oct 13, 2020
Chimeric cytokine receptors and encoding nucleic acids
AUTOLUS LTD6 citations83
US10800855B2Oct 13, 2020
Chimeric cytokine receptors and encoding nucleic acids
AUTOLUS LTD4 citations83
US10954530B2Mar 23, 2021
Retroviral and lentiviral vectors
AUTOLUS LTD5 citations82
US12187769B2Jan 7, 2025
Cell
AUTOLUS LTD2 citations74
US11058722B2Jul 13, 2021
Chimeric antigen receptor comprising a cartilage-oligomeric matrix protein (comp) coiled-coil spacer domain
AUTOLUS LTD4 citations73
US11851672B2Dec 26, 2023
CAR T-cells comprising transcriptional circuits
AUTOLUS LTD3 citations72
US11479613B2Oct 25, 2022
Methods for treating cancer or modulating T cells or NK cells in a subject by administering cells comprising chimeric transmembrane proteins
AUTOLUS LTD1 citations72
US11365262B2Jun 21, 2022
Cell
AUTOLUS LTD4 citations72
US12049510B2Jul 30, 2024
Chimeric antigen receptor
AUTOLUS LTD2 citations71
US11590170B2Feb 28, 2023
Chimeric antigen receptor
AUTOLUS LTD3 citations71
US11180553B2Nov 23, 2021
Chimeric antigen receptor
AUTOLUS LTD4 citations71
US11466070B2Oct 11, 2022
Signalling system
AUTOLUS LTD2 citations69
US10919951B2Feb 16, 2021
Chimeric antigen receptor
AUTOLUS LTD2 citations69
US11103532B2Aug 31, 2021
Chimeric protein
AUTOLUS LTD2 citations68
US12398194B2Aug 26, 2025
Cell lexpressing two chimeric antigen receptors (CARs) at the cell surface
AUTOLUS LTD0 citations62
US12234295B2Feb 25, 2025
Chimeric transmembrane protein comprising antibody dimerization domains and a type I cytokine receptor endodomain, encoding nucleic acids thereof and methods of use thereof
AUTOLUS LTD0 citations62
US11959084B2Apr 16, 2024
Nucleic acid construct
AUTOLUS LTD1 citations62
US11879016B2Jan 23, 2024
Chimeric antigen receptor
AUTOLUS LTD0 citations62
US11701386B2Jul 18, 2023
Cell
AUTOLUS LTD1 citations62
US11648274B2May 16, 2023
Polypeptide
AUTOLUS LTD0 citations62
US11479614B2Oct 25, 2022
Methods for treating cancer or modulating T cells or NK cells in a subject with cancer by administering cells comprising chimeric cytokine receptors
AUTOLUS LTD0 citations62
US11242377B2Feb 8, 2022
Chimeric receptor with ligand binding exodomain and cytokine and T cell signalling endodomains
AUTOLUS LTD1 citations62
US10975162B2Apr 13, 2021
Chimeric antigen receptor
AUTOLUS LTD1 citations62
US12454578B2Oct 28, 2025
Cytolytic immune cell comprising BCMA- and CD19-specific chimeric antigen receptors
AUTOLUS LTD0 citations61
US11345734B2May 31, 2022
Chimeric T cell
AUTOLUS LTD1 citations61
US12516119B2Jan 6, 2026
Anti TRBC1 antigen binding domains
AUTOLUS LTD0 citations60
US11982673B2May 14, 2024
Methods
AUTOLUS LTD0 citations60
US11982672B2May 14, 2024
Methods
AUTOLUS LTD0 citations60
US11963981B2Apr 23, 2024
Chimeric antigen receptor
AUTOLUS LTD0 citations60
US11885807B2Jan 30, 2024
Method for depleting malignant T-cells
AUTOLUS LTD0 citations60
US11885806B2Jan 30, 2024
Method for depleting malignant T-cells
AUTOLUS LTD0 citations60
US11814641B2Nov 14, 2023
Retroviral and lentiviral vectors
AUTOLUS LTD0 citations60
US11385233B2Jul 12, 2022
Methods of depleting malignant T-cells
AUTOLUS LTD1 citations60
US12492410B2Dec 9, 2025
Engineered cytolytic immunecell
AUTOLUS LTD0 citations59
US11578126B2Feb 14, 2023
Chimeric antigen receptor (CAR) comprising a CD19-binding domain
AUTOLUS LTD1 citations58
US12269860B2Apr 8, 2025
Compositions and methods comprising engineered chimeric antigen receptor and modulator of CAR
AUTOLUS LTD0 citations57
US11945867B2Apr 2, 2024
T-cell receptor constant region 1 antibody or T-cell receptor constant region 2 antibody
AUTOLUS LTD0 citations57
US11965173B2Apr 23, 2024
Plasmid system
AUTOLUS LTD0 citations55
US11643453B2May 9, 2023
Cell
AUTOLUS LTD1 citations55
US11591613B2Feb 28, 2023
Retroviral and lentiviral vectors
AUTOLUS LTD1 citations55
US12304942B2May 20, 2025
Cell comprising a chimeric antigen receptor or a transgenic T-cell receptor and comprising a chimeric TNF receptor
AUTOLUS LTD0 citations54
US11613559B2Mar 28, 2023
Nucleic acid construct
AUTOLUS LTD0 citations52
US11530420B2Dec 20, 2022
Nucleic acid construct
AUTOLUS LTD0 citations52
US12241068B2Mar 4, 2025
CD79-specific chimeric antigen receptor
AUTOLUS LTD0 citations51
US11903967B2Feb 20, 2024
Method of preparing T cells with increased activity
AUTOLUS LTD0 citations51
Showing the top 50 of 53 patents by PatentIndex Score.